Pain sensitivity and descending inhibition of pain in Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 1, 2009, Pages 24-28

  Mylius, V ^a   Engau, I ^a   Teepker, M ^b   Stiasny Kolster, K ^a   Schepelmann, K ^b   Oertel, W H ^c   Lautenbacher, S ^a   Moller J C ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF BAMBERG   (Germany)

^c MLK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRICITY; FEMALE; FLEXOR REFLEX; GENE LOCUS; HEATING; HUMAN; MALE; NERVE STIMULATION; NOCICEPTION; PAIN THRESHOLD; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPINE; AGED; ELECTROSTIMULATION; HEAT; MIDDLE AGED; NERVE CELL INHIBITION; NOCICEPTIVE RECEPTOR; PAIN; PHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ELECTRIC STIMULATION; FEMALE; HOT TEMPERATURE; HUMANS; MALE; MIDDLE AGED; NEURAL INHIBITION; NOCICEPTORS; PAIN; PAIN THRESHOLD; PARKINSON DISEASE;

EID: 58249087803     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2008.145995     Document Type: Article

References (40)

1. Ford B. Pain in Parkinson's disease. Clin Neurosci 1998; 5:63-72.
2. Giuffrida R, Wngerhoets FJ, Bogousslavsky J, et al. Pain in Parkinson's disease. Rev Neurol (Paris) 2005; 161:407-18.
3. Lee MA, Walker RW, Hildreth TJ, et al. A survey of pain in idiopathic Parkinson's disease. J Pain Symptom Manage 2006; 32:462-9.
4. Tinazzi M, Del Vesco C, Fincati E, et al. Pain and motor complications in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77:822-5.
5. Brefel-Courbon C, Payoux P, Thalamas C, et al. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov Disord 2005; 20:1557-63.
6. Gerdelat-Mas A, Simonetta-Moreau M, Thalamas C, et al. Levodopa raises objective pain threshold in Parkinson's disease: a Rlll reflex study. J Neurol Neurosurg Psychiatry 2007; 78:1140-2.
7. Barnes CD, Fung SJ, Adams WL. Inhibitory effects of substantia nigra on impulse transmission from nociceptors. Pain 1979; 6:207-15.
8. Burkey AR, Carstens E, Jasmin L. Dopamine reuptake inhibition in the rostral agranular insular cortex produces antinociception. J Neurosci 1999; 19:4169-79.
9. Le Bars D. The whole body receptive field of dorsal horn multireceptive neurones. Brain Res Brain Res Rev 2002; 40:29-44.
10. Kosek E, Ordeberg G. Lack of pressure pain modulation by heterotopic noxious conditioning stimulation in patients with painful osteoarthritis before, but not following, surgical pain relief. Pain 2000; 88:69-78.
11. Lautenbacher S, Rollman GB. Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain 1997; 13:189-96.
12. Pielsticker A, Haag G, Zaudig M, et al. Impairment of pain inhibition in chronic tension-type headache. Pain 2005; 118:215-23.
13. Chudler EH, Dong WK. The role of the basal ganglia in nociception and pain. Pain 1995; 60:3-38.
14. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51:745-52.
15. Foistein MF, Robins LN, Helzer JE. The Mini-Mental State Examination. Arch Gen Psychiatry 1983; 40:812.
16. Sheikh Jl, Yesavage JA, Brooks JO 3rd. et al. Proposed factor structure of the Geriatric Depression Scale. Int Psychogeriatr 1991; 3:23-8.
17. Wilier JC. Comparative study of perceived pain and nociceptive flexion reflex in man. Pain 1977; 3:69-80.
18. Sandrini G, Serrao M, Rossi P. et al. The lower limb flexion reflex in humans. Prog Neurobiol 2005; 77:353-95.
19. France CR, Froese SA, Stewart JC. Altered central nervous system processing of noxious stimuli contributes to decreased nociceptive responding in individuals at risk for hypertension. Pain 2002; 98:101-8.
20. Mylius V, Kunz M, Schepelmann K, et al. Sex differences in nociceptive withdrawal reflex and pain perception. Somatosens Mot Res 2005; 22:207-11.
21. Levitt H. Transformed up-down methods in psychoacoustics. J Acoust Soc Am 1971; 49(Suppl 2):467.
22. Lautenbacher S, Roscher S, Strian F. Inhibitory effects do not depend on the subjective experience of pain during heterotopic noxious conditioning stimulation (HNCS): a contribution to the psychophysics of pain inhibition. Eur J Pain 2002; 6:365-74.
23. Wilier JC, Roby A, Le Bars D. Psychophysical and electrophysiological approaches to the pain-relieving effects of heterotopic nociceptive stimuli. Brain 1984: 107:1095-112.
24. Möller JC, Korner Y, Dodel RC, et al. Pharmacotherapy of Parkinson's disease in Germany. J Neurol 2005; 252:926-35.
25. Djaldetti R, Shifrin A, Rogowski Z, et al. Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology 2004; 62:2171-5.
26. Guieu R, Pouget J, Serratrice G. Nociceptive threshold and Parkinson disease. Rev Neurol (Paris) 1992; 148:641-4.
27. Liu QS, Qiao JT, Dafny N. D2 dopamine receptor involvement in spinal dopammeproduced antinociception. Life Sci 1992; 51:1485-92.
28. Magnusson JE, Fisher K. The involvement of dopamine in nociception: the role of D(1) and D(2) receptors in the dorsolateral striatum. Brain Res 2000; 855:260-6.
29. Giesecke T, Gracely RH, Grant MA, et al. Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum 2004; 50:613-23.
30. Kosek E, Ordeberg G. Abnormalities of somatosensory perception in patients with painful osteoarthritis normalize following successful treatment. Eur J Pain 2000; 4:229-38.
31. Chrtour D, Dickenson AH, Le Bars D. Pharmacological evidence for the involvement of serotonergic mechanisms in diffuse noxious inhibitory controls (DNIC). Brain Res 1982; 236:329-37.
32. Le Bars D, Wilier JC, De Broucker T. Morphine blocks descending pain inhibitory controls in humans. Pain 1992; 48:13-20.
33. Wilier JC, Le Bars D, De Broucker T. Diffuse noxious inhibitory controls in man: involvement of an opioidergic link. Eur J Pharmacol 1990; 182:347-55.
34. Braak H, Del Tredici K. Rub U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24:197-211.
35. Halliday GM, Blumbergs PC, Cotton RG, et al. Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease. Brain Res 1990; 510:104-7.
36. Jellinger K. New developments in the pathology of Parkinson's disease. Adv Neurol 1990; 53:1-16.
37. Scatton B, Javoy-Agid F, Rouquier L, et al. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res 1983; 275:321-8.
38. Thomas E, Peat G, Harris L, et al. The prevalence of pain and pain interference in a general population of older adults: cross-sectional findings from the North Staffordshire Osteoarthritis Project (NorStOP). Pain 2004; 110:361-8.
39. Zarow C, Lyness SA, Mortimer JA, et al. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 2003; 60:337-41.
40. Lautenbacher S, Prager M, Rollman GB. Pain additivity, diffuse noxious inhibitory controls, and attention: A functional measurement analysis. Somatosens Mot Res 2007; 24:189-201.